Macrocyclics2023價格表-上海起發(fā)
Macrocyclics公司專門生產(chǎn)各種高分子環(huán)化合物，包括蛋白質(zhì)、核酸和碳水化合物等。這些產(chǎn)品廣泛用于生物醫(yī)學(xué)研究、診斷和治療。 Macrocyclics以其高質(zhì)量的產(chǎn)品和客戶服務(wù)而享有良好的聲譽(yù)。
| 貨號 | 品名 | 規(guī)格 | 價格 | 品牌 | 貨期 | 價格來源 |
| B-605:B-605-50 | p-SCN-Bn-NOTA, 50mg | 50mg | 8060 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-605:B-605-500 | p-SCN-Bn-NOTA, 500mg | 500mg | 52420 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-616:B-616-100 | NO2A-Butyne-bis(t-Butyl ester), 100mg | 100mg | 18280 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-616:B-616-500 | NO2A-Butyne-bis(t-Butyl ester), 500mg | 500mg | 62000 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-620:B-620-1 | NOTA-bis(t-Bu ester),1g | 1g | 26080 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-620:B-620-100 | NOTA-bis(t-Bu ester),100mg | 100mg | 4560 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-620:B-620-500 | NOTA-bis(t-Bu ester),500mg | 500mg | 18760 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-622:B-622-100 | Maleimido-mono-amide-NOTA,100mg | 100mg | 10740 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-622:B-622-500 | Maleimido-mono-amide-NOTA,500mg | 500mg | 31260 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-626:B-626-100 | NO2A-Butyne, 100mg | 100mg | 26460 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-626:B-626-500 | NO2A-Butyne, 500mg | 500mg | 92540 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-628:B-628-100 | NO2A-Azide, 100mg | 100mg | 11260 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-628:B-628-500 | NO2A-Azide, 500mg | 500mg | 32660 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-664:B-664-1 | 2-[1,4,7-Triazacyclononan-1-yl-4,7-bis(tBu-ester)]-1,5-pentanedioic acid, 1g | 1g | 47040 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-664:B-664-100 | 2-[1,4,7-Triazacyclononan-1-yl-4,7-bis(tBu-ester)]-1,5-pentanedioic acid, 100mg | 100mg | 8280 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-664:B-664-500 | 2-[1,4,7-Triazacyclononan-1-yl-4,7-bis(tBu-ester)]-1,5-pentanedioic acid, 500mg | 500mg | 31440 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-705:B-705-100 | Deferoxamine-p-SCN-Bn, 100mg | 100mg | 9720 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-705:B-705-50 | Deferoxamine-p-SCN-Bn, 50mg | 50mg | 6160 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-705:B-705-500 | Deferoxamine-p-SCN-Bn, 500mg | 500mg | 33540 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-772:B-772-100 | Deferroxamine-maleimide, 100mg | 100mg | 8080 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-772:B-772-50 | Deferroxamine-maleimide, 50mg | 50mg | 5120 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-772:B-772-500 | Deferroxamine-maleimide, 500mg | 500mg | 27800 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-773:B-773-100 | Deferoxamine-DBCO, 100mg | 100mg | 12180 | Macrocyclics | 4-6周 | 上海起發(fā) |
| B-773:B-773-50 | Deferoxamine-DBCO, 50mg | 50mg | 8980 | Macrocyclics | 4-6周 | 上海起發(fā) |
| C-100:C-100-100 | DOTA-Biotin-Sarcosine, 100mg | 100mg | 38620 | Macrocyclics | 4-6周 | 上海起發(fā) |
| C-100:C-100-20 | DOTA-Biotin-Sarcosine, 20mg | 20mg | 9480 | Macrocyclics | 4-6周 | 上海起發(fā) |
| C-100:C-100-50 | DOTA-Biotin-Sarcosine, 50mg | 50mg | 19840 | Macrocyclics | 4-6周 | 上海起發(fā) |
| C-210:C-210-100 | DO3A-Serotonin, 100mg | 100mg | 9380 | Macrocyclics | 4-6周 | 上海起發(fā) |
| C-210:C-210-500 | DO3A-Serotonin, 500mg | 500mg | 37660 | Macrocyclics | 4-6周 | 上海起發(fā) |
| C-220:C-220-1 | DOTATATE, DOTA-d-Phe-Cys-Tyr-d-Trp-Lys-Thr-Cys-Thr, 1mg | 1mg | 7140 | Macrocyclics | 4-6周 | 上海起發(fā) |
| C-220:C-220-5 | DOTATATE, DOTA-d-Phe-Cys-Tyr-d-Trp-Lys-Thr-Cys-Thr, 5mg | 5mg | 25480 | Macrocyclics | 4-6周 | 上海起發(fā) |
| D-100:D-100-10 | EAM-1,N,N,N,-Trimethyl-2[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]ethanaminium iodide ,10mg | 10mg | 8100 | Macrocyclics | 4-6周 | 上海起發(fā) |
| I-121:I-121-5 | Bis-CBZ-Cyclen (1,4,7,10-Tetraazacyclododecane-1,7-bis(benzylcarbamide), 5g | 5g | 27860 | Macrocyclics | 4-6周 | 上海起發(fā) |
| I-131:I-131-1 | TrisBOC-Cyclen(1,4,7,10-Tetraazacyclododecane),1g | 1g | 3900 | Macrocyclics | 4-6周 | 上海起發(fā) |
| I-131:I-131-5 | TrisBOC-Cyclen(1,4,7,10-Tetraazacyclododecane),5g | 5g | 17440 | Macrocyclics | 4-6周 | 上海起發(fā) |
| I-623:I-623-1 | NO2A-(t-Bu ester), 1g | 1g | 19520 | Macrocyclics | 4-6周 | 上海起發(fā) |
| I-623:I-623-500 | NO2A-(t-Bu ester), 500mg | 500mg | 11640 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-100:M-100-1 | Cyclen (1,4,7,10-Tetraazacyclododecane), 1g | 1g | 1000 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-100:M-100-10 | Cyclen (1,4,7,10-Tetraazacyclododecane), 10g | 10g | 11120 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-100:M-100-25 | Cyclen (1,4,7,10-Tetraazacyclododecane), 25g, | 25g | 24680 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-100:M-100-5 | Cyclen (1,4,7,10-Tetraazacyclododecane), 5g | 5g | 5640 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-120:M-120-1 | DO2A-t-Bu-ester (1,4,7,10-Tetraazacyclodecane-1,7-bis (t-butyl acetate), 1g | 1g | 6020 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-120:M-120-5 | DO2A-t-Bu-ester (1,4,7,10-Tetraazacyclodecane-1,7-bis (t-butyl acetate), 5g | 5g | 25180 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-120:M-120-500 | DO2A-t-Bu-ester (1,4,7,10-Tetraazacyclodecane-1,7-bis (t-butyl acetate), 500mg | 500mg | 3940 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-125:M-125-1 | DO2A(1,4,7,10-Tetraazacyclododecane-1,7-bis(acetic acid), 1g | 1g | 20000 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-125:M-125-500 | DO2A (1,4,7,10-Tetraazacyclododecane-1,7-bis(acetic acid), 500mg | 500mg | 11060 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-130:M-130-1 | DO3A-t-Bu-ester (1,4,7,10-Tetraazacyclododecane-1,4,7-tris (t-butyl acetate), 1g, | 1g | 2940 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-130:M-130-5 | DO3A-t-Bu-ester (1,4,7,10-Tetraazacyclododecane-1,4,7-tris (t-butyl acetate), 5g | 5g | 12900 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-130:M-130-500 | DO3A-t-Bu-ester (1,4,7,10-Tetraazacyclododecane-1,4,7-tris (t-butyl acetate), 500mg | 500mg | 2180 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-135:M-135-1 | DO3A, 1g, Tetraazacyclododecane-1,4,7- triacetic acid trisodium salt, 1g | 1g | 14880 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-135:M-135-500 | DO3A,500mg, Tetraazacyclododecane-1,4,7- triacetic acid trisodium salt, 500mg | 500mg | 8540 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-140:M-140-1 | DOTA (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid), 1g | 1g | 3320 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-140:M-140-25 | DOTA (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid), 25g | 25g | 58200 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-140:M140-5 | DOTA (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid), 5g | 5g | 14080 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-145:M-145-1 | Tm-DOTA, 1g | 1g | 9240 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-145:M-145-500 | Tm-DOTA,500mg | 500mg | 5040 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-147:M-147-1 | Gd-DOTA, 1g | 1g | 7920 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-147:M-147-500 | Gd-DOTA, 500mg | 500mg | 4520 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-150:M-150-1 | DOTP (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra (methylene phosphonic acid), 1g | 1g | 2000 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-150:M-150-10 | DOTP (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra (methylene phosphonic acid), 10g | 10g | 11860 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-150:M-150-5 | DOTP (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra (methylene phosphonic acid), 5g, | 5g | 6400 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-155:M-155-1 | Tm[DOTP], (Thulium(III) (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra (methylenephosphonate))), 1g | 1g | 3600 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-155:M-155-10 | Tm[DOTP], (Thulium(III) (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra (methylenephosphonate))), 10g | 10g | 29380 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-155:M-155-100 | Tm[DOTP], (Thulium(III) (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra (methylenephosphonate))), 100g | 100g | 271640 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-160:M-160-1 | DOTMA,1g | 1g | 21580 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-160:M-160-100 | DOTMA, 100mg | 100mg | 3880 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-160:M-160-500 | DOTMA, 500mg, | 500mg | 12080 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-165:M-165-1 | TmDOTMA, 1g | 1g | 29220 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-165:M-165-500 | TmDOTMA, 500mg | 500mg | 18760 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-170:M-170-1 | TETA (1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic acid), 1g | 1g | 20580 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-170:M-170-5 | TETA (1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic acid), 5g | 5g | 85900 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-170:M-170-500 | TETA (1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic acid), 500mg | 500mg | 11300 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-180:M-180-1 | DOTAM (1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane), 1g | 1g | 2280 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-180:M-180-5 | DOTAM (1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane), 5g | 5g | 10560 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-180:M-180-500 | DOTAM (1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane), 500mg | 500mg | 1240 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-190:M-190-1 | DiAmSar,1g | 1g | 18020 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-190:M-190-100 | DiAmSar,100mg | 100mg | 7020 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-190:M-190-5 | DiAmSar,5g | 5g | 76440 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-190:M-190-500 | DiAmSar, 500mg | 500mg | 23100 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-200:M-200-1 | CB-Cyclam,1g | 1g | 15280 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-200:M-200-500 | CB-Cyclam, 500mg | 500mg | 9840 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-220:M-220-100 | CB-TE2A,1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-4,11-diacetic acid,100mg | 100mg | 2620 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-220:M-220-500 | CB-TE2A, ,4,8,11-tetraazabicyclo[6.6.2]hexadecane-4,11-diacetic acid,500mg | 500mg | 10360 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-400:M-400-100 | DOTA-4AMP, 100mg | 100mg | 8440 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-400:M-400-500 | DOTA-4AMP, 500mg | 500mg | 21760 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-503:M503-100 | EuDOTA-4AmC, 100mg | 100mg | 6480 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-503:M-503-50 | EuDOTA-4AmC, 50mg | 50mg | 3660 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-503:M-503-500 | EuDOTA-4AmC, 500mg | 500mg | 14880 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-600:M-600-1 | NOTA,1,4,7-Triazacyclononane-1,4,7-triacetic acid,1g | 1g | 17160 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-600:M-600-500 | NOTA,1,4,7-Triazacyclononane-1,4,7-triacetic acid, 500mg | 500mg | 11900 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-650:M-650-1 | NOTP, 1g | 1g | 4580 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-650:M-650-5 | NOTP, 5g, | 5g | 19440 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-90:M-90-1 | TACN 1,4,7-triazacylononane 1.0g/each..(triaza) | 1.0g/each | 2940 | Macrocyclics | 4-6周 | 上海起發(fā) |
| M-90:M-90-5 | TACN 1,4,7-triazacylononane 5.0g/each..(triaza), | 5.0g/each | 13420 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-205:X-205-100 | Tm-p-SCN-Bn-DOTA,100mg, Thulium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, | 100mg | 27260 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-205:X-205-50 | Tm-p-SCN-Bn-DOTA, 50mg,Thulium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, | 50mg | 16020 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-207:X-207-100 | Gd-p-SCN-Bn-DOTA, 100mg | 100mg | 27260 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-207:X-207-50 | Gd-p-SCN-Bn-DOTA, 50 mg | 50 mg | 16020 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-209:X-209-100 | Ho-p-SCN-Bn-DOTA, 100mg , Holmium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid | 100mg | 27260 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-209:X-209-50 | Ho-p-SCN-Bn-DOTA, 50mg , Holmium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid | 50mg | 16020 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-275:X-275-100 | Tm-Maleimido-DOTA, 100mg, Thulium (III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-10-maleimidoethylacetamide | 100mg | 18400 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-275:X-275-50 | Tm-Maleimido-DOTA, 50mg, Thulium (III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-10-maleimidoethylacetamide | 50mg | 10600 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-279:X-279-100 | Ho-Maleimido-DOTA, 100mg,Holmium (III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-10-maleimidoethylacetamide | 100mg | 18400 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-279:X-279-50 | Ho-Maleimido-DOTA, 50mg,Holmium (III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-10-maleimidoethylacetamide | 50mg | 10600 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-287:X-287-100 | Gd-DO3A-Butylamine, 100mg, Gadolinium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(4-aminobutyl)acetamide | 100mg | 11380 | Macrocyclics | 4-6周 | 上海起發(fā) |
| X-287:X-287-500 | Gd-DO3A-Butylamine, 500mg, Gadolinium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(4-aminobutyl)acetamide | 500mg | 44220 | Macrocyclics | 4-6周 | 上海起發(fā) |
| Bifunctional Starter Pack (#S-100) | B205 - 50mg B280 - 100mg B305 - 100mg B355 - 50mg | 50mg | 18520 | Macrocyclics | 4-6周 | 上海起發(fā) |
關(guān)鍵詞：Macrocyclics；Macrocyclics授權(quán)代理；DOTA-NHS-ester；p-SCN-Bn-DOTA；Macrocyclics B-280-500mg
